Genomic Tests Eliminate ‘Diagnostic Odysseys’ ̶ Why Are They Underutilized In The UK?
Executive Summary
Genomic diagnostics provide significant value to the health system, but England’s unclear funding pathways and commissioning processes are preventing these tests from reaching patients, a report by trade body BIVDA reveals.